Skip to main content
. Author manuscript; available in PMC: 2020 Aug 14.
Published in final edited form as: Leukemia. 2020 Feb 14;34(7):1741–1750. doi: 10.1038/s41375-020-0741-0

Figure 3: MRD kinetics during ALL therapy on survival from MPAL.

Figure 3:

For children with WHO2008 MPAL receiving a Children’s Oncology Group ALL induction and consolidation, those achieving earlier MRD negativity (<0.01%) at end of induction experienced higher event-free (A) and overall (B) survival from end of consolidation than those patients becoming MRD negative only after consolidation. Patients with unknown end consolidation MRD are not shown.